Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 12-Nov-25 | 10058.40 | 0.58% | - | 0.12% | 64/229 |
| 1 Month | 17-Oct-25 | 10211.00 | 2.11% | - | 0.84% | 48/228 |
| 3 Month | 19-Aug-25 | 10285.70 | 2.86% | - | 3.11% | 127/224 |
| 6 Month | 19-May-25 | 10478.40 | 4.78% | - | 6.49% | 141/214 |
| YTD | 01-Jan-25 | 9728.30 | -2.72% | - | 5.66% | 172/200 |
| 1 Year | 19-Nov-24 | 10477.90 | 4.78% | 4.78% | 8.66% | 135/187 |
| 2 Year | 17-Nov-23 | 14398.20 | 43.98% | 19.90% | 19.55% | 63/143 |
| Since Inception | 14-Dec-22 | 17573.00 | 75.73% | 21.18% | 14.38% | 37/200 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 19-Nov-24 | 12000 | 12481.93 | 4.02 % | 7.49 % |
| 2 Year | 17-Nov-23 | 24000 | 26758.59 | 11.49 % | 10.81 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 201.4 | 22.18% | 0.57% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -0.25 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 96.8 | 10.66% | 1.36% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.36 k | -27.00 |
| Cipla Ltd. | Pharmaceuticals | 95.5 | 10.51% | -0.37% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.59 k | -0.13 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.5 | 9.08% | -0.51% | 10.28% (Dec 2024) | 9.08% (Oct 2025) | 68.88 k | -0.14 k |
| Lupin Ltd. | Pharmaceuticals | 53.7 | 5.91% | -0.03% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.35 k | -56.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 42.1 | 4.64% | -0.21% | 4.85% (Sep 2025) | 3.83% (Dec 2024) | 11.83 k | -21.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 41.9 | 4.61% | 0.41% | 4.61% (Oct 2025) | 2.87% (Nov 2024) | 43.92 k | -89.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 36 | 3.97% | 0.07% | 4.55% (Nov 2024) | 3.67% (Aug 2025) | 31.62 k | -63.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 35.1 | 3.86% | -0.07% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.37 k | -9.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 32.2 | 3.55% | -0.24% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.03 k | -33.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.67% |
| Net Receivables | Net Receivables | -0.65% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
Out of 109 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 9 is/are ranked 3 * , 5 is/are ranked 2 * , 3 is/are ranked 1 * , and 78 schemes are not ranked. See more about AMC